Comment on: "Exploring the best treatment options for BRAF-mutant metastatic colon cancer"

Br J Cancer. 2020 May;122(11):1724-1725. doi: 10.1038/s41416-020-0819-5. Epub 2020 Mar 31.

Authors

Gérard Milano¹, Jocelyn Gal²

Affiliations

¹ Oncopharmacology Unit and UNS EA 7497, Centre Antoine Lacassagne, University Côte d'Azur, Nice, F-06189, France. gerard.milano@nice.unicancer.fr.
² Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, Nice, F-06189, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

Colonic Neoplasms* / drug therapy
Colonic Neoplasms* / genetics
Colorectal Neoplasms* / drug therapy
Colorectal Neoplasms* / genetics
Humans
Proto-Oncogene Proteins B-raf / genetics
Rectal Neoplasms*

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf